High tetracycline resistance percentages in in Europe: is doxycycline post-exposure prophylaxis unlikely to reduce the incident gonorrhoea cases?
作者信息
Unemo Magnus, Cole Michelle J, Kodmon Csaba, Day Michaela, Jacobsson Susanne
机构信息
WHO Collaborating Centre for Gonorrhoea and Other STIs, National Reference Laboratory for STIs, Department of Laboratory Medicine, Faculty of Medicine and Health, Örebro University, Örebro, Sweden.
Institute for Global Health, University College London (UCL), London, UK.
出版信息
Lancet Reg Health Eur. 2024 Feb 13;38:100871. doi: 10.1016/j.lanepe.2024.100871. eCollection 2024 Mar.
Abstract
摘要
相似文献
1
High tetracycline resistance percentages in in Europe: is doxycycline post-exposure prophylaxis unlikely to reduce the incident gonorrhoea cases?
Lancet Reg Health Eur. 2024 Feb 13;38:100871. doi: 10.1016/j.lanepe.2024.100871. eCollection 2024 Mar.
2
Antimicrobial resistance in Neisseria gonorrhoeae isolates and gonorrhoea treatment in the Republic of Belarus, Eastern Europe, 2009-2019.
BMC Infect Dis. 2021 Jun 2;21(1):520. doi: 10.1186/s12879-021-06184-7.
3
A genomic perspective on the near-term impact of doxycycline post-exposure prophylaxis on antimicrobial resistance.
medRxiv. 2023 Mar 17:2023.03.14.23287223. doi: 10.1101/2023.03.14.23287223.
4
Antimicrobial susceptibility of Neisseria gonorrhoeae isolates and treatment of gonorrhoea patients in Ternopil and Dnipropetrovsk regions of Ukraine, 2013-2018.
APMIS. 2019 Jul;127(7):503-509. doi: 10.1111/apm.12948. Epub 2019 May 21.
5
Incidence and antimicrobial susceptibility of Neisseria gonorrhoeae isolates from patients attending the national Neisseria gonorrhoeae reference laboratory of Hungary.
BMC Infect Dis. 2014 Aug 6;14:433. doi: 10.1186/1471-2334-14-433.
6
Antimicrobial resistance and molecular epidemiological typing of Neisseria gonorrhoeae isolates from Kyrgyzstan in Central Asia, 2012 and 2017.
BMC Infect Dis. 2021 Jun 12;21(1):559. doi: 10.1186/s12879-021-06262-w.
7
Doxycycline Postexposure Prophylaxis Could Induce Cross-Resistance to Other Classes of Antimicrobials in Neisseria gonorrhoeae : An In Silico Analysis.
Sex Transm Dis. 2023 Aug 1;50(8):490-493. doi: 10.1097/OLQ.0000000000001810. Epub 2023 Mar 23.
8
High percentages of resistance to tetracycline and penicillin and reduced susceptibility to azithromycin characterize the majority of strain types of Neisseria gonorrhoeae isolates in Cuba, 1995-1998.
Sex Transm Dis. 2003 May;30(5):443-8. doi: 10.1097/00007435-200305000-00012.
9
Incidence and duration of incident oropharyngeal gonorrhoea and chlamydia infections among men who have sex with men: prospective cohort study.
Sex Transm Infect. 2021 Sep;97(6):452-457. doi: 10.1136/sextrans-2020-054764. Epub 2020 Nov 18.
10
Antimicrobial resistance and Neisseria gonorrhoeae multiantigen sequence typing (NG-MAST) genotypes in N. gonorrhoeae during 2012-2014 in Karachi, Pakistan.
BMC Infect Dis. 2016 Jul 22;16:353. doi: 10.1186/s12879-016-1673-1.
引用本文的文献
1
DoxyPEP: Opportunities for Expansion.
J Prim Care Community Health. 2025 Jan-Dec;16:21501319251370497. doi: 10.1177/21501319251370497. Epub 2025 Sep 6.
2
Tetracycline-resistant global estimates-impacts on doxycycline post-exposure prophylaxis implementation and monitoring: a systematic review.
JAC Antimicrob Resist. 2025 Jul 9;7(4):dlaf120. doi: 10.1093/jacamr/dlaf120. eCollection 2025 Aug.
3
Emergent informal use of doxycycline post- and pre-exposure prophylaxis among men who have sex with men and transgender and gender diverse people, the Netherlands, 2024.
Euro Surveill. 2025 Jul;30(26). doi: 10.2807/1560-7917.ES.2025.30.26.2400707.
4
Revisiting the potential impact of doxycycline post-exposure prophylaxis on the selection of doxycycline resistance in Neisseria commensals.
Sci Rep. 2025 Apr 11;15(1):12400. doi: 10.1038/s41598-025-96244-8.
5
Re-visiting the potential impact of doxycycline post-exposure prophylaxis (doxy-PEP) on the selection of doxycycline resistance in commensals.
bioRxiv. 2025 Jan 9:2025.01.09.632169. doi: 10.1101/2025.01.09.632169.
本文引用的文献
1
Using doxycycline for prophylaxis of bacterial sexually transmitted infections: considerations for the European Union and European Economic Area.
Euro Surveill. 2023 Nov;28(46). doi: 10.2807/1560-7917.ES.2023.28.46.2300621.
2
Genomic surveillance and antimicrobial resistance determinants in Neisseria gonorrhoeae isolates from Uganda, Malawi and South Africa, 2015-20.
J Antimicrob Chemother. 2023 Aug 2;78(8):1982-1991. doi: 10.1093/jac/dkad193.
3
Important considerations regarding the widespread use of doxycycline chemoprophylaxis against sexually transmitted infections.
J Antimicrob Chemother. 2023 Jul 5;78(7):1561-1568. doi: 10.1093/jac/dkad129.
4
Postexposure Doxycycline to Prevent Bacterial Sexually Transmitted Infections.
N Engl J Med. 2023 Apr 6;388(14):1296-1306. doi: 10.1056/NEJMoa2211934.
5
Post-exposure prophylaxis with doxycycline to prevent sexually transmitted infections in men who have sex with men: an open-label randomised substudy of the ANRS IPERGAY trial.
Lancet Infect Dis. 2018 Mar;18(3):308-317. doi: 10.1016/S1473-3099(17)30725-9. Epub 2017 Dec 8.
6
A trial of minocycline given after exposure to prevent gonorrhea.
N Engl J Med. 1979 May 10;300(19):1074-8. doi: 10.1056/NEJM197905103001903.
Zotero 插件